BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Dev California Life Sciences - ECPv6.1.2.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Dev California Life Sciences
X-ORIGINAL-URL:https://dev.califesciences.org
X-WR-CALDESC:Events for Dev California Life Sciences
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220222T160000
DTEND;TZID=America/Los_Angeles:20220222T180000
DTSTAMP:20260407T074751
CREATED:20220218T174339Z
LAST-MODIFIED:20220225T170324Z
UID:6479-1645545600-1645552800@dev.califesciences.org
SUMMARY:Women in Bio - SoCal Chapter Presents "Rare Disease 8: Intersecting Access & Diversity for Underserved Communities"
DESCRIPTION:Join us for a discussion on improving patient access to healthcare in under-represented communities\, the importance of diversifying clinical trials\, and exploring rare diseases that affect Black\, Indigenous\, and People of Color (BIPOC) women. \nRegister»
URL:https://dev.califesciences.org/event/women-in-bio-socal-chapter-presents-rare-disease-8-intersecting-access-diversity-for-underserved-communities/
LOCATION:Live\, Online
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-15.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220224
DTEND;VALUE=DATE:20220225
DTSTAMP:20260407T074751
CREATED:20220225T000201Z
LAST-MODIFIED:20220225T193055Z
UID:6647-1645660800-1645747199@dev.califesciences.org
SUMMARY:Leadership Edge: From the Laboratory to Leadership
DESCRIPTION:From The Laboratory To Leadership: 25th Anniversary Edition\, turns science minded managers into capable business leaders. That means they’ll get the core management skills they need to fully leverage your company’s human capital. This virtual program is delivered over four (4) days\, with each full day session spaced two (2) weeks apart. \nWho should participate? \nThe program is designed for science-minded\, first-time managers\, as well as\, managers seeking to expand their management skills. While the majority of participants are scientists who have been promoted to a management or team leader position\, the program also supports the development of those who serve in other management roles in a life science company\, whether that is in a quality\, manufacturing\, regulatory\, clinical or administrative function. The program is also an excellent way to develop high potential\, individual contributors\, whom you are readying for promotion. \nProgram Dates: 8:30am – 3:30pm\, February 24\, March 10\, March 24\, and April 7 \nCLS Members receive a $500 discount on registration. \n  \nRegister»
URL:https://dev.califesciences.org/event/leadership-edge-from-the-laboratory-to-leadership-q1-2022/
LOCATION:Live\, Online
CATEGORIES:Professional Development
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-11.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220225T103000
DTEND;TZID=America/Los_Angeles:20220225T113000
DTSTAMP:20260407T074751
CREATED:20220131T213754Z
LAST-MODIFIED:20220225T162946Z
UID:6263-1645785000-1645788600@dev.califesciences.org
SUMMARY:Driving the Bioscience Economy Forward During the COVID-19 Pandemic: Best practices in State and Regional Economic Development Initiatives
DESCRIPTION:Join us for our next Conversation with Thought Leaders as we focus on the findings from BIO’s new report on bioscience economic development best practices. Speakers from BIO and CLS will discuss public policy strategies and programs across the country\, with a focus on California\, and highlight new and innovative initiatives that enhance the future of the bioscience industry. \nRegister»
URL:https://dev.califesciences.org/event/conversation-with-thought-leaders-driving-the-bioscience-economy-forward-during-the-covid-19-pandemic-best-practices-in-state-and-regional-economic-development-initiatives/
LOCATION:Live\, Online
CATEGORIES:Curated Events
ATTACH;FMTTYPE=image/png:https://dev.califesciences.org/wp-content/uploads/2022/01/MicrosoftTeams-image-10.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220309
DTEND;VALUE=DATE:20220311
DTSTAMP:20260407T074751
CREATED:20220224T234342Z
LAST-MODIFIED:20220225T163553Z
UID:6644-1646784000-1646956799@dev.califesciences.org
SUMMARY:MDMA: 2022 FDA Forum
DESCRIPTION:MDMA’s 2022 FDA Forum will feature senior officials from FDA and industry and focus on the\nkey regulatory issues impacting the medical device industry. \nDesigned specifically for medical device regulatory professionals and executive decision makers\,\nMDMA’s FDA Forum promises to deliver key regulatory insights and preview trends\nthat will impact your regulatory and business strategies. \nTopics will include: \nFDA’s Continued COVID-19 Response\nNavigating 510(k)\, De Novo\, PMA Programs\nDigital Health\nCDRH Update\nBest Practices for Pre-Submission meetings\nEmerging Issues (Biocompatibility\, Supply Chain & More)\nMDUFA Update \nThis conference is pre-approved by RAPS as eligible for up to 6 credits towards a participant’s RAC recertification upon full completion \nCLS Members receive $100 off registration using code STATE at checkout.  \n  \nRegister»
URL:https://dev.califesciences.org/event/mdma-2022-fda-forum/
LOCATION:Live\, Online
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-13.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220315T120000
DTEND;TZID=America/Los_Angeles:20220315T133000
DTSTAMP:20260407T074751
CREATED:20220131T214530Z
LAST-MODIFIED:20220224T210204Z
UID:6271-1647345600-1647351000@dev.califesciences.org
SUMMARY:CLSFAST Opening Showcase
DESCRIPTION:The FAST Program provides select entrepreneurs with intensive team review and coaching to perfect their business model\, product development plans\, and to build a compelling commercialization strategy. Emerging innovators benefit from the advice and counsel of industry veterans – custom-selected from the FAST network of over 425 professionals comprised of entrepreneurs\, product\, and business experts (i.e.\, clinical development\, regulatory\, reimbursement\, and business development specialists) – during the twelve-week program. \n \nThe Opening Showcase is by invitation only\, for our program advisors and sponsors. Sponsorship opportunities range from $7\,500 – $25\,000. To learn more\, please visit https://www.califesciences.org/fast-program/. To become a sponsor\, please contact Emily Morgan\, Programs Director\, at emorgan@califesciences.org.  \nThank you to our 2022 Sponsors:
URL:https://dev.califesciences.org/event/clsfast-opening-showcase/
LOCATION:Live\, Online
CATEGORIES:Community Initiatives & Programs,Industry Collaboration & Networking
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-6.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220316T110000
DTEND;TZID=America/Los_Angeles:20220316T113000
DTSTAMP:20260407T074751
CREATED:20220302T234427Z
LAST-MODIFIED:20220304T001319Z
UID:6766-1647428400-1647430200@dev.califesciences.org
SUMMARY:Using STEP and SciLeads To Grow Your California Biotech Business
DESCRIPTION:Join the live webinar with Laura Haldane as she introduces SciLeads\, an innovative life science and applied research lead generation platform. SciLeads works with bioscience companies in California and around the world to accelerate their sales by enabling them to quickly find and engage with targeted and funded leads\, and develop outreach strategies. \nAlso joining Laura is Mariana Guevara from the California Governor’s Office of Business and Economic Development who will speak about how the STEP grant program can contribute toward the cost of the SciLeads database subscription. \nRegister»
URL:https://dev.califesciences.org/event/using-step-and-scileads-to-grow-your-california-biotech-business/
LOCATION:Live\, Online
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/03/258762_CLS_22_Event_Graphics-13-450x254-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220325T080000
DTEND;TZID=America/Los_Angeles:20220325T090000
DTSTAMP:20260407T074751
CREATED:20220310T224234Z
LAST-MODIFIED:20220310T224337Z
UID:6894-1648195200-1648198800@dev.califesciences.org
SUMMARY:Halloran Town Hall: Total Data Control and Custody – Moving from Excel to Complete Integration for Better Clinical Trial Decisions
DESCRIPTION:We have certainly come a long way in clinical trial operations over the past few years as our industry collectively shifted to decentralized and hybrid models to collect patient data outside of the traditional site model. And sponsors have a lot of data. This growth\, though celebrated\, also comes with growing pains\, like figuring how to build a large data mapping infrastructure to harness the trial’s data for better insight and oversight. \nIf you’re experiencing a similar issue\, please join our Halloran-hosted virtual Town Hall on March 25\, 2022\, from 11:00a.m. – 12:00p.m. EST on “Total Data Control and Custody: Moving from Excel to Complete Integration for Better Clinical Trial Decisions” led by the global data strategy and innovation team at CSL Behring and joined by experts from Halloran. CSL Behring has recently designed a data infrastructure for their studies that allowed their teams to have better control over their data\, leading to more informed decisions. They have major lessons learned and context behind their change and will be sharing their insights with the panel (and you!) to work through the following: \nHow do you integrate data sources and automate processes to get to a point of total data control regardless of company size? \nHow to get executive buy-in around data standards and oversight? \nWhat does the planning entail? Where do we start? \nIs this the future of data? How should companies prepare? \nIf you too want to evolve in this direction\, there is significant time and money that will need to be spent well in advance of when the trial data needs to be submitted. So\, let’s brainstorm and learn from each other. We hope you can join us – and bring your questions – to talk through scenarios for better data strategy\, control\, and custody for better decision making. \nMeet the Panel: \nMeghan Powers\, Director\, Clinical Practice Operations\, Halloran Consulting Group; Karen Travers\, Associate Principal Consultant\, Organizational & Quality Solutions\, Halloran Consulting Group; Thomas Verish\, Head of Global Data Strategy & Innovation\, CSL Behring; Valerie Reynaert\, Head of Global Clinical Operations\, CSL Behring; Charles Johnson\, Director\, eClinical Operations\, CSL Behring; Tony Ciliberto\, Senior Director\, Global Clinical Operations\, CSL Behring \nRegister» \nUpon registration you will receive a calendar invite with Zoom info.
URL:https://dev.califesciences.org/event/halloran-town-hall-total-data-control-and-custody-moving-from-excel-to-complete-integration-for-better-clinical-trial-decisions/
LOCATION:Live\, Online
CATEGORIES:Industry Supported,Member Events
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-12.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220329T113000
DTEND;TZID=America/Los_Angeles:20220329T121500
DTSTAMP:20260407T074751
CREATED:20220301T004358Z
LAST-MODIFIED:20220301T212752Z
UID:6736-1648553400-1648556100@dev.califesciences.org
SUMMARY:National Life Science Startup Symposium - "FDA For Life Science Companies: The Insiders Guide to FDA Approval"
DESCRIPTION:Kwame Ulmer is a 12 year veteran of the FDA and currently works as a regulatory strategist and investor. You will learn how to develop a regulatory strategy\, maximize your interactions with the FDA and efficiently get your product approved. The presentation is geared towards helping C-Suite executives understand the key levers to drive premarket approval and compliance attractive to investors. The presentation will also discuss overcoming the regulatory challenges during COVID.
URL:https://dev.califesciences.org/event/national-life-science-startup-symposium-fda-for-life-science-companies-the-insiders-guide-to-fda-approval/
LOCATION:Live\, Online
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-13-450x254-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220511T090000
DTEND;TZID=America/Los_Angeles:20220511T100000
DTSTAMP:20260407T074751
CREATED:20220419T193126Z
LAST-MODIFIED:20220420T155241Z
UID:8070-1652259600-1652263200@dev.califesciences.org
SUMMARY:IQVIA - Critical Success Factors For Commercialization Series - Emerging Biopharma Prevailing Trends
DESCRIPTION:The number of biopharma and biotech companies developing and launching new therapies is continuing to rise with emerging biopharma remaining a strong source of innovation. At the same time\, more barriers to success are emerging with requirements for increasingly complex clinical trials\, continuous regulatory changes\, evolving payer conditions\, and more restrictive access to HCPs. \nIt’s evident that asset success starts early\, with a need to ensure evidence generation delivers endpoints that demonstrate value to regulators\, payers\, prescribers\, and patients. Communicating that value requires an adaptable\, omnichannel approach to activate and engage all stakeholders for launch and throughout the product lifecycle. \nLearn how IQVIA is helping clinical and commercial customers bring therapies to market and to the patients who need them. \nIQVIA experts will break down the components of successful commercialization for emerging biopharma and biotech companies. \nEmerging Biopharma Prevailing Trends \nHear key insights from the recently published IQVIA Institute report on the contribution of emerging biopharma to development and commercialization\, as well as prevailing commercial launch trends and the implications for a successful asset strategy. \nRegister» \nAsk the experts \nIQVIA experts will take your questions at the end of each session. If they are unable to address every question live\, they will follow up with an answer individually to ensure you have the information you need.
URL:https://dev.califesciences.org/event/iqvia-critical-success-factors-for-commercialization/
LOCATION:Live\, Online
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-13.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220512T090000
DTEND;TZID=America/Los_Angeles:20220512T100000
DTSTAMP:20260407T074751
CREATED:20220419T195644Z
LAST-MODIFIED:20220420T154527Z
UID:8076-1652346000-1652349600@dev.califesciences.org
SUMMARY:IQVIA - Critical Success Factors For Commercialization Series - Preparing to Enter the Market: A Focus on Market Access
DESCRIPTION:The number of biopharma and biotech companies developing and launching new therapies is continuing to rise with emerging biopharma remaining a strong source of innovation. At the same time\, more barriers to success are emerging with requirements for increasingly complex clinical trials\, continuous regulatory changes\, evolving payer conditions\, and more restrictive access to HCPs. \nIt’s evident that asset success starts early\, with a need to ensure evidence generation delivers endpoints that demonstrate value to regulators\, payers\, prescribers\, and patients. Communicating that value requires an adaptable\, omnichannel approach to activate and engage all stakeholders for launch and throughout the product lifecycle. \nLearn how IQVIA is helping clinical and commercial customers bring therapies to market and to the patients who need them. \nIQVIA experts will break down the components of successful commercialization for emerging biopharma and biotech companies. \nPreparing to Enter the Market: A Focus on Market Access \nAsset success relies on strong engagement with the key stakeholders who will influence the path to the patient. Learn from IQVIA experts as they share key considerations for emerging biopharma companies who need to establish market access in the U.S. \nRegister» \nAsk the experts \nIQVIA experts will take your questions at the end of each session. If they are unable to address every question live\, they will follow up with an answer individually to ensure you have the information you need.
URL:https://dev.califesciences.org/event/iqvia-critical-success-factors-for-commercialization-series-preparing-to-enter-the-market-a-focus-on-market-access/
LOCATION:Live\, Online
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-13.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220518T090000
DTEND;TZID=America/Los_Angeles:20220518T120000
DTSTAMP:20260407T074751
CREATED:20220419T200018Z
LAST-MODIFIED:20220420T163902Z
UID:8078-1652864400-1652875200@dev.califesciences.org
SUMMARY:IQVIA – Critical Success Factors For Commercialization Series – Asset Success Starts Early: Demonstrating and Communicating the Value of Your Therapy
DESCRIPTION:The number of biopharma and biotech companies developing and launching new therapies is continuing to rise with emerging biopharma remaining a strong source of innovation. At the same time\, more barriers to success are emerging with requirements for increasingly complex clinical trials\, continuous regulatory changes\, evolving payer conditions\, and more restrictive access to HCPs. \nIt’s evident that asset success starts early\, with a need to ensure evidence generation delivers endpoints that demonstrate value to regulators\, payers\, prescribers\, and patients. Communicating that value requires an adaptable\, omnichannel approach to activate and engage all stakeholders for launch and throughout the product lifecycle. \nLearn how IQVIA is helping clinical and commercial customers bring therapies to market and to the patients who need them. \nIQVIA experts will break down the components of successful commercialization for emerging biopharma and biotech companies. \nAsset Success Starts Early: Demonstrating and Communicating the Value of Your Therapy \nIQVIA experts will share perspectives on how emerging biopharma companies can demonstrate and communicate the value of new therapies by engaging thought leaders to ensure their innovation reaches the patients who need it. \nRegister» \nAsk the experts \nIQVIA experts will take your questions at the end of each session. If they are unable to address every question live\, they will follow up with an answer individually to ensure you have the information you need.
URL:https://dev.califesciences.org/event/iqvia-critical-success-factors-for-commercialization-series-asset-success-starts-early-demonstrating-and-communicating-the-value-of-your-therapy/
LOCATION:Live\, Online
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-13.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220519T090000
DTEND;TZID=America/Los_Angeles:20220519T100000
DTSTAMP:20260407T074751
CREATED:20220419T200521Z
LAST-MODIFIED:20220420T155511Z
UID:8080-1652950800-1652954400@dev.califesciences.org
SUMMARY:IQVIA - Critical Success Factors For Commercialization - Innovative Customer Engagement Models
DESCRIPTION:The number of biopharma and biotech companies developing and launching new therapies is continuing to rise with emerging biopharma remaining a strong source of innovation. At the same time\, more barriers to success are emerging with requirements for increasingly complex clinical trials\, continuous regulatory changes\, evolving payer conditions\, and more restrictive access to HCPs. \nIt’s evident that asset success starts early\, with a need to ensure evidence generation delivers endpoints that demonstrate value to regulators\, payers\, prescribers\, and patients. Communicating that value requires an adaptable\, omnichannel approach to activate and engage all stakeholders for launch and throughout the product lifecycle. \nLearn how IQVIA is helping clinical and commercial customers bring therapies to market and to the patients who need them. \nIQVIA experts will break down the components of successful commercialization for emerging biopharma and biotech companies. \nInnovative Customer Engagement Models \nWhile the value of face-to-face\, personal HCP interactions remain impactful\, the efficacy\, adoption\, and ROI of digital\, non-personal engagement continues to increase. IQVIA experts will discuss the imperatives for an agile and flexible engagement model for emerging biopharma; one that’s fit for today’s realities while being ready for what tomorrow will bring. \nRegister» \nAsk the experts \nIQVIA experts will take your questions at the end of each session. If they are unable to address every question live\, they will follow up with an answer individually to ensure you have the information you need.
URL:https://dev.califesciences.org/event/iqvia-critical-success-factors-for-commercialization-innovative-customer-engagement-models/
LOCATION:Live\, Online
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-13.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220811T090000
DTEND;TZID=America/New_York:20220811T130000
DTSTAMP:20260407T074751
CREATED:20220414T195142Z
LAST-MODIFIED:20220420T164018Z
UID:7834-1660208400-1660222800@dev.califesciences.org
SUMMARY:Public Health & Its Access to Historically Excluded Communities\, Pt. 4  Actualizing Change
DESCRIPTION:In jurisdictions as large and diverse as California\, the understanding of health equity and how to apply best practices could not be more pressing. Improving and assuring racial equity above racial equality has been shown to reduce inequity in healthcare outcomes through community-level investment\, equitable leadership development\, and most importantly increased access to timely and culturally responsive healthcare and treatment. Please join Ace Robinson\, California Life Sciences\, and Center for Excellence in Nonprofits for this four-part series exploring these topics. Participants will leave with a customized playbook on how to increase access and improve health outcomes for historically excluded communities. \nRegister»
URL:https://dev.califesciences.org/event/public-health-its-access-to-historically-excluded-communities-pt-4-actualizing-change/
LOCATION:Live\, Online
CATEGORIES:Member Events,Professional Development
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-12.jpg
END:VEVENT
END:VCALENDAR